The process of developing a biosimilar and bringing it to market can be a lengthy, expensive process. It is crucial for sponsor organizations to understand the policies that are currently set in order to develop strategies to allow biosimilar drugs to access the marketplace. With a limited number of biosimilars available competition is at an all-time high. However, once you gain approval the real challenge becomes sustaining market success. There is a significant market opportunity ahead for biosimilar developers if they can figure out a strategic plan to enhance the commercialization of the biosimilar.

Whether you are exploring your chances of tapping into the competitive biosimilars marketplace or are an expert in the field, the 2nd Biosimilar Market Access and Commercialization Strategies Summit will provide detailed presentations, intensive case studies and collaborative panel discussions relevant to your interests.

Our talented faculty will address everything from navigating evolving regulations, analyzing optimal pricing models, accelerating market access strategies, and executing strategic decisions to mitigate risk and build for commercial success. Also designated lunches and networking breaks will enhance the exchange of knowledge and foster future business partnerships.